[18F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.
AuteursChan DL, Hayes A, Karfis I, Conner A, Mileva M, Bernard E, Navalkissoor S, Gnanasekaran G, Clarke SJ, Roach PJ, Flamen P, Caplin ME, Pavlakis N, Toumpanakis C, Bailey DL
Patients with status epilepticus and new-onset refractory status epilepticus display drastically altered fecal microbiomes compared to chronic epilepsy patients.
AuteursSteriade C, Thomas SC, Xu F, Ahituv A, Hanin A, Pleshkevich M, Hwang S, Ramirez A, Foreman B, Yoo J, Eka O, Kellogg M, Oliger A, Wainwright MS, Morales M, Gaspard N, Hirsch LJ, Devinsky O, Saxena D